Epigenetic Reader Domain Ligand

PROTAC BRD4 ligand-3 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). PROTAC BRD4 ligand-3 can be used for synthesis PROTAC BRD4 Degrader-27 (HY-162875).

UNO peptide is a MRC1-expressing TAMs (MEMs)-targeting peptide. UNO peptide targets CD206 on MEMs across a spectrum of solid tumors. UNO peptide can be used in the research of MEMs in breast cancer.

BRD9 ligand-7 is a Ligand for Target Protein for PROTAC. CSI118 TFA can be used to synthesize BRD9 Degrader-1 (HY-156401).

PROTAC BRD4 ligand-2 is a ligand for target BRD4 protein for PROTAC CFT-2718.

BRD9 ligand-12 is a BRD9 ligand. BRD9 ligand-12 can be used as a ligand for target protein for PROTAC to develop and design degradative agents for PROTAC BRD9, such as XYD270 (HY-182082). XYD270 inhibits tumor growth in a mouse model of acute myeloid leukemia. XYD270 can be used in research related to synovial sarcoma and acute myeloid leukemia.

BRD9 ligand-10 is a ligand targeting BRD9. BRD9 ligand-10 can be used as a target protein ligand for the synthesis of PROTAC BRD9 Degrader-10 (HY-181949).

F2276-0106 is a biochemical reagent targeting the PCAF bromodomain (PDB 5FDZ). F2276-0106 is predicted to have good cell permeability and oral absorption, with physicochemical properties consistent with Lipinski's rule of five. F2276-0106 can be used in cancer-related research.

BRD4 ligand 13 is a BRD4 ligand that can be used for the synthesis of PROTACs, such as Cath-L-dBET1 (HY-173257). BRD4 ligand 13 is a target protein ligand-conjugate that can be used for the synthesis of PROTACs, such as SJH1-51B (HY-162240).

BRD4 ligand 10 is a PROTAC target protein ligand. BRD4 ligand 10 can be used to synthesize PROTAC BRD4 Degrader-49 (HY-185854).